Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03137875|
Recruitment Status : Completed
First Posted : May 3, 2017
Last Update Posted : May 3, 2017
Specimen transport from peripheral health structures to the National TB reference laboratory for MDR-TB identification presents a big challenge in term of sample management, safety, contamination and delays. Thus a system that allows specimen to be collected and shipped in a safely manner while reducing the possibilities of contamination, the cost of shipment and especially the time for detection of MDR-TB by using molecular methods would be very useful. Whereas the some studies show promising results for the development and standardization of simple specimen collection and transportation methods for molecular DST, more data is needed before these can be used in routine.
The study described here aims at identifying a suitable method, in terms of adapted sample support (s) (slide, filter paper (FTA, Genocard ...)) and DNA extraction method. If one or several methods are found to give satisfying results, then a larger patient based evaluation of this (these) method(s) for molecular DST will be performed in a second phase. The protocol for the second phase will be prepared separately.
|Condition or disease|
|Tuberculosis Multi Drug Resistant Tuberculosis|
The main objective of this study is to evaluate the performance of PCR in identification and detection of tuberculosis using DNA extracts from stained slides (Ziehl Neelsen and Fluorescence) and Filter paper (FTA card and Genocard).
The secondary objectives of this study are to assess the MTB extraction yield from smear-negative, low and high bacilli load specimens on slides, filter paper ( Genocardand FTA), to determine the amount of sample required to make a detectable PCR reaction and to assess the feasibility of storage and extraction methods.
|Study Type :||Observational|
|Actual Enrollment :||122 participants|
|Official Title:||Evaluation of the PCR Using DNA Extracts From Stained Slides and Sputum Collected on Filter Paper for Identification and Detection of Tuberculosis and Multidrug Resistant (MDR) Tuberculosis|
|Study Start Date :||March 2011|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||December 2012|
Patient with sputum smear positive 2+
patient who will have a positive diagnostic of tuberculosis using microscopy with a 2+ grade
patient smear positive scanty or 1+
patient who will have a positive diagnostic of tuberculosis using microscopy with a scanty or 1+ grade
patient smear negative
patient with a negative TB microscopy result
- proportion of positive samples for Mycobacterium tuberculosis detected by PCR from slides and filter papers among samples by microscopy [ Time Frame: 6 MONTHS ]Tests
- To assess the MTB extraction yield from smear-negative, low and high bacilli load specimens on slides, filter paper ( Genocardand FTA) [ Time Frame: 6 MONTHS ]Tests
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03137875
|Epicentre Mbarara Research Base|
|Study Director:||Yap JB Boum II, PhD||Epicentre Mbarara|